Loading clinical trials...
Loading clinical trials...
The goal of this protocol, broadly stated, is to use targeted manipulations with intranasally administered oxytocin (OT) and arginine vasopressin (AVP) in conjunction with neurocognitive and neuroimag...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
National Institute of Mental Health (NIMH)
NCT05543083 · Insulin Resistance, Depression, and more
NCT05712057 · Emotion Regulation, Mood Disorders, and more
NCT06854367 · Late Life Depression (LLD), Depression - Major Depressive Disorder, and more
NCT07211750 · Multimorbidity, Older Adults (65 Years and Older), and more
NCT05658796 · Mood Disorders, Anxiety, and more
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions